Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Sujet principal
Gamme d'année
1.
Am J Health Syst Pharm ; 74(24): 2060-2064, 2017 Dec 15.
Article de Anglais | MEDLINE | ID: mdl-29222363

RÉSUMÉ

PURPOSE: Development of a stability-indicating high-performance liquid chromatography (HPLC) method for pyrimethamine analysis, with subsequent application of that method to assess the 90-day stability of a pyrimethamine suspension compounded from bulk USP-grade pyrimethamine powder, is described. METHODS: A stability-indicating method of HPLC with ultraviolet detection specific to pyrimethamine was developed according to pharmacopeial recommendations and validated. The method was applied to investigate the stability of a 2-mg/mL pyrimethamine suspension in a vehicle consisting of Ora-Plus and Ora-Sweet (Perrigo) over a period of 90 days. Three replicate test preparations were stored at room temperature or refrigerated at 4.3-5.2 °C, and samples were analyzed in duplicate immediately after preparation and on study days 1, 2, 4, 7, 10, 14, 21, 30, 48, 60, 75, and 90. RESULTS: The 2-mg/mL suspension of pyrimethamine in Ora-Plus and Ora-Sweet retained 90-110% of the labeled potency to 90 days at both temperature ranges. However, color changes in the samples stored at room temperature observed at day 60 indicated that a beyond-use date less than 90 days from the preparation date should be specified when the suspension is to be stored at room temperature. CONCLUSION: The study demonstrated that USP-grade pyrimethamine powder can be formulated as a 2-mg/mL suspension in a vehicle of Ora-Plus and Ora-Sweet and is stable when stored at room temperature and when refrigerated, in amber plastic bottles, for 48 and 90 days, respectively.


Sujet(s)
Pyriméthamine/analyse , Chromatographie en phase liquide à haute performance , Couleur , Préparation de médicament , Stabilité de médicament , Stockage de médicament , Véhicules pharmaceutiques , Poudres , Pyriméthamine/administration et posologie , Reproductibilité des résultats , Sensibilité et spécificité , Spectrophotométrie UV , Suspensions
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE